Amalgamated Bank Krystal Biotech, Inc. Transaction History
Amalgamated Bank
- $13.6 Billion
- Q3 2025
A detailed history of Amalgamated Bank transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 7,416 shares of KRYS stock, worth $1.51 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,416
Previous 7,226
2.63%
Holding current value
$1.51 Million
Previous $993,000
31.82%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding KRYS
# of Institutions
316Shares Held
24.6MCall Options Held
400KPut Options Held
467K-
Black Rock Inc. New York, NY3.95MShares$801 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.79MShares$567 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.66MShares$540 Million6.67% of portfolio
-
State Street Corp Boston, MA1.36MShares$275 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA942KShares$191 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $5.21B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...